Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3278-3283

  Eloot, Sunny ^a   Dhondt, Annemieke ^a   Van Landschoot, Mieke ^a   Waterloos, Marie Anne ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

adequacy; haemodiafiltration; mid dilution; protein bound; solute removal

Indexed keywords

3 CARBOXYL 4 METHYL 5 PROPYL 2 FURANPROPIONIC ACID; 4 CRESYLSULFATE; CREATININE; HIPPURIC ACID; INDICAN; INDOLEACETIC ACID; PROPIONIC ACID; SULFATE; UNCLASSIFIED DRUG; UREA; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD SAMPLING; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE LEVEL; EXTRACTION; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HEMODILUTION; HUMAN; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SOLUTE;

AGED; AGED, 80 AND OVER; CROSS-OVER STUDIES; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN BINDING; SOLUBILITY; TOXINS, BIOLOGICAL; UREMIA; WATER;

EID: 84864577568     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs060     Document Type: Article

References (36)

1. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
2. Vanholder R, Glorieux G, De Smet R et al. New insights in uremic toxins. Kidney Int Suppl 2003; 63: S6-10.
3. Cheung AK, Rocco MV, Yan G et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-555.
4. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019.
5. Meert N, Beerenhout C, Schepers E et al. Evolution of protein-bound uraemic solutes during predilution haemofiltration. J Nephrol 2009; 22: 352-357.
6. Meert N, Waterloos MA, Van Landschoot M et al. Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 2010; 34: 580-585.
7. Meert N, Eloot S, Schepers E et al. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant 2011; 26: 2624-2630.
8. Canaud B, Bragg-Gresham JL, Marshall MR et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006; 69: 2087-2093.
9. Jirka T, Cesare S, Di Benedetto A et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int 2006; 70: 1524-1525.
10. Locatelli F, Marcelli D, Conte F et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 1999; 55: 286-293.
11. Santoro A, Mancini E, Bolzani R et al. The effect of on-line highflux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis 2008; 52: 507-518.
12. Bammens B, Evenepoel PImproving removal of protein-bound retention solutes. Contrib Nephrol 2005; 149: 175-184.
13. Meert N, Eloot S, Waterloos MA et al. Effective removal of proteinbound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 2009; 24: 562-570.
14. Krieter DH, Hackl A, Rodriguez A et al. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 2010; 25: 212-218.
15. Adijiang A, Goto S, Uramoto S et al. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant 2008; 23: 1892-1901.
16. Bammens B, Evenepoel P, Keuleers H et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087.
17. Barreto FC, Barreto DV, Liabeuf S et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 1551-1558.
18. Dou L, Bertrand E, Cerini C et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004; 65: 442-451.
19. Liabeuf S, Barreto DV, Barreto FC et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 1183-1191.
20. Meijers BK, Bammens B, De Moor B et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008; 73: 1174-1180.
21. Meijers BK, Van Kerckhoven S, Verbeke K et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54: 891-901.
22. Niwa T, Takeda N, Tatematsu A et al. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem 1988; 34: 2264-2267.
23. Schepers E, Meert N, Glorieux G et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 2007; 22: 592-596.
24. Yamamoto H, Tsuruoka S, Ioka T et al. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 2006; 69: 1780-1785.
25. Yu MA, Sanchez-Lozada LG, Johnson RJ et al. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010; 28: 1234-1242.
26. Zoccali C, Maio R, Mallamaci F et al. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006; 17: 1466-1471.
27. Santoro A, Canova C, Mancini E et al. Protein loss in on-line hemofiltration. Blood Purif 2004; 22: 261-268.
28. Krieter DH, Falkenhain S, Chalabi L et al. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration. Kidney Int 2005; 67: 349-356.
29. Pedrini LA, Feliciani A, Zerbi S et al. Optimization of mid-dilution haemodiafiltration: technique and performance. Nephrol Dial Transplant 2009; 24: 2816-2824.
30. Daugirdas JTSecond generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
31. Fagugli RM, De Smet R, Buoncristiani U et al. Behavior of nonprotein- bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 2002; 40: 339-347.
32. Canaud B, Levesque R, Krieter D et al. On-line hemodiafiltration as routine treatment of end-stage renal failure: why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today?. Blood Purif 2004; 22Suppl 240-48.
33. Feliciani A, Riva MA, Zerbi S et al. New strategies in haemodiafiltration (HDF): prospective comparative analysis between on-line mixed HDF and mid-dilution HDF. Nephrol Dial Transplant 2007; 22: 1672-1679.
34. Santoro A, Ferramosca E, Mancini E et al. Reverse mid-dilution: new way to remove small and middle molecules as well as phosphate with high intrafilter convective clearance. Nephrol Dial Transplant 2007; 22: 2000-2005.
35. Bammens B, Evenepoel P, Verbeke K et al. Removal of the proteinbound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis 2004; 44: 278-285.
36. Susantitaphong P, Tiranathanagul K, Hanvivatvong O et al. A simple efficient technique of 'mid-dilution' on-line hemodiafiltration. Blood Purif 2009; 28: 93-101